(Q53427484)

14 May 2018

title

9-Hydroxyellipticine inhibits telomerase activity in human pancreatic cancer cells. (English)

1 reference

14 May 2018

main subject

9-hydroxyellipticine

1 reference

ChEBI release 2020-05-28

1 reference

Sato N

1

1 reference

14 May 2018

Mizumoto K

2

1 reference

14 May 2018

Kusumoto M

3

1 reference

14 May 2018

Niiyama H

4

1 reference

14 May 2018

Maehara N

5

1 reference

14 May 2018

Ogawa T

6

1 reference

14 May 2018

Tanaka M

7

1 reference

14 May 2018

language of work or name

English

0 references

publication date

1 December 1998

1 reference

14 May 2018

published in

FEBS Letters

1 reference

14 May 2018

volume

441

1 reference

14 May 2018

issue

2

1 reference

14 May 2018

page(s)

318-321

1 reference

14 May 2018

Structure and function of telomeres

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901571-3

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901571-3

Clinical implications of telomerase in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901571-3

A survey of telomerase activity in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901571-3

Semi-quantitative analysis of telomerase in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901571-3

Preclinical and clinical strategies for development of telomerase and telomere inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901571-3

Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901571-3

Inhibition of human telomerase activity by peptide nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901571-3

The RNA component of human telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901571-3

Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901571-3

Modulation of telomerase activity by telomere DNA-binding proteins in Oxytricha

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901571-3

Telomerase activation by the E6 gene product of human papillomavirus type 16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901571-3

The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901571-3

Inhibition of p53 Protein Phosphorylation by 9‐Hydroxyellipticine: A Possible Anticancer Mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901571-3

Reduced telomeric signals and increased telomeric associations in human lung cancer cell lines undergoing p53-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901571-3

Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901571-3

Inhibition of telomerase activity by cisplatin in human testicular cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901571-3

A novel cytotoxicity screening assay using a multiwell fluorescence scanner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901571-3

In vivo stimulation by antitumor drugs of the topoisomerase II induced cleavage sites in c-myc protooncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901571-3

Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901571-3

10.1016/S0014-5793(98)01571-3

7 January 2021

Identifiers

DOI

1 reference

14 May 2018

PubMed ID

9883907

1 reference

14 May 2018